Amedisys Stock Market Value
| AMED Stock | USD 98.25 0.50 0.51% |
| Symbol | Amedisys |
Amedisys Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.81 | Revenue Per Share 70.107 | Quarterly Revenue Growth 0.069 | Return On Assets 0.0638 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amedisys 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amedisys' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amedisys.
| 06/26/2024 |
| 07/26/2024 |
If you would invest 0.00 in Amedisys on June 26, 2024 and sell it all today you would earn a total of 0.00 from holding Amedisys or generate 0.0% return on investment in Amedisys over 30 days. Amedisys is related to or competes with Acadia Healthcare, Addus HomeCare, Encompass Health, Ensign, Option Care, Universal Health, and Surgery Partners. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States More
Amedisys Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amedisys' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amedisys upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.03 | |||
| Information Ratio | 0.0352 | |||
| Maximum Drawdown | 6.92 | |||
| Value At Risk | (0.59) | |||
| Potential Upside | 1.05 |
Amedisys Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amedisys' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amedisys' standard deviation. In reality, there are many statistical measures that can use Amedisys historical prices to predict the future Amedisys' volatility.| Risk Adjusted Performance | 0.0811 | |||
| Jensen Alpha | 0.1237 | |||
| Total Risk Alpha | (0) | |||
| Sortino Ratio | 0.0356 | |||
| Treynor Ratio | (0.53) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amedisys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Amedisys Backtested Returns
At this point, Amedisys is very steady. Amedisys secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Amedisys, which you can use to evaluate the volatility of the firm. Please confirm Amedisys' mean deviation of 0.5174, and Risk Adjusted Performance of 0.0811 to double-check if the risk estimate we provide is consistent with the expected return of 0.11%. Amedisys has a performance score of 8 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Amedisys are expected to decrease at a much lower rate. During the bear market, Amedisys is likely to outperform the market. Amedisys right now shows a risk of 1.07%. Please confirm Amedisys treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to decide if Amedisys will be following its price patterns.
Auto-correlation | -0.86 |
Excellent reverse predictability
Amedisys has excellent reverse predictability. Overlapping area represents the amount of predictability between Amedisys time series from 26th of June 2024 to 11th of July 2024 and 11th of July 2024 to 26th of July 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amedisys price movement. The serial correlation of -0.86 indicates that approximately 86.0% of current Amedisys price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.86 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Amedisys lagged returns against current returns
Autocorrelation, which is Amedisys stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Amedisys' stock expected returns. We can calculate the autocorrelation of Amedisys returns to help us make a trade decision. For example, suppose you find that Amedisys has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Amedisys regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Amedisys stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Amedisys stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Amedisys stock over time.
Current vs Lagged Prices |
| Timeline |
Amedisys Lagged Returns
When evaluating Amedisys' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Amedisys stock have on its future price. Amedisys autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Amedisys autocorrelation shows the relationship between Amedisys stock current value and its past values and can show if there is a momentum factor associated with investing in Amedisys.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Amedisys Stock
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:Check out Amedisys Correlation, Amedisys Volatility and Amedisys Alpha and Beta module to complement your research on Amedisys. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Amedisys technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.